Drugs / Tritanrix™-HepB low thio
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01061541 | Aug 2003 → Jan 2004 | haemophilus infectious disease | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tritanrix-HepB low thio | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01061541 ↗ |
| Modality | Vaccine | “investigational DTPw-HBVLT/Hib2.5 vaccine” PMID 20657177 ↗ Aug 2010 |
| Route | Intramuscular | “One dose as intramuscular injection at 6, 10 and 14 weeks of age.” NCT01061541 ↗ |